RGEN FY 2021 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

FY 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$671M+83.1% YoY

Gross Profit

$391M58.3% margin

Operating Income

$167M24.9% margin

Net Income

$128M19.1% margin

EPS (Diluted)

$2.24

Cash Flow

Operating Cash Flow

$119M

Free Cash Flow

$48M

Stock-Based Comp.

$28M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$608M

Stockholders' Equity

$1.8B

Cash & Equivalents

$604M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$671M	$366M	+83.1%
Gross Profit	$391M	$194M	+101.3%
Operating Income	$167M	$81M	+105.7%
Net Income	$128M	$60M	+114.1%